跳至主要内容
临床试验/NCT06666387
NCT06666387已完成不适用

The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.

Siemens Healthcare A/S2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2024年10月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
2
主要终点
Evaluation of the diagnostic image quality (software and hardware) of the novel combined PET-MR system NextGen PET-MR in the clinical setting.

研究概览

简要总结

This clinical investigation is used to evaluate the novel PET-MR scanner and it is a clinical investigation under MDR.

The focus is on the evaluation of the diagnostic image quality in a clinical setting, considering the speed of the examination and the new functionalities to minimize the patient's lying times. Based on the assessment, the defined protocols and measurement sequences are further improved as necessary to optimize the clinical value of the sequences and user interface components.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult test subjects for whom a PET-MR examination is indicated and will be performed, or
  • Test subjects for whom a PET-CT examination is indicated and will be performed
  • Test subjects of legal age who have given their written informed consent to participate in the clinical investigation
  • Written consent of the test subject to be informed in the event of suspected clinically relevant incidental findings
  • Written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality)
  • The test subject´s written consent that the recorded image data may be made available to Siemens Healthcare A/S in pseudonymized form
  • Test subjects whose weight does not exceed the permissible weight limit of the patient table (200 kg).

排除标准

  • Metal in and on the body that causes stress to the test subject during an examination in the FoV of the combined PET-MR system
  • All pacemakers and other implants
  • Pregnancy: The exclusion of test subjects of childbearing potential is carried out based on a positive pregnancy test
  • Test subjects who indicate an increased sensitivity to loud noises
  • Test subjects who are incapable of giving consent.

研究组 & 干预措施

PET-MR examination

Other

干预措施: PET-MR examination (Diagnostic Test)

结局指标

主要结局

Evaluation of the diagnostic image quality (software and hardware) of the novel combined PET-MR system NextGen PET-MR in the clinical setting.

时间窗: Estimated 5 months

The outcome of this clinical investigation for conformity assessment according to §62 MDR is the performance and safety to show the indirect clinical benefit. The performance includes diagnostic image quality (including general image quality of the software features, resolution, occurrence of artifacts, etc.) as well as the functionality including system stability of the novel PET-MR system in the clinical setting. The diagnostic image quality, image noise, contrast and resolution for each acquired sequence is rated by two investigators of each specialization (nuclear medicine and radiology) using a 5-point Likert scale. The rating is done for MR images of body regions whole body, total body, brain, head/neck and pelvis fused with PET images of different tracers for all participants. The test in a region of the body is considered successful if the mean value of all scores in that region reaches a value of t ≤ 2.5. In case the mean value for a certain software feature does not reach 2.

次要结局

未报告次要终点

研究者

发起方
Siemens Healthcare A/S
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验